Antitumor effects of IOX1 combined with bevacizumab-induced apoptosis and immunity on colorectal cancer cells

贝伐单抗 结直肠癌 细胞凋亡 免疫 医学 癌症研究 癌症 肿瘤科 免疫学 免疫系统 内科学 生物 化疗 遗传学
作者
Shuilong Fang,Huicun Cao,Jian Liu,Guangshao Cao,Tianxiao Li
出处
期刊:International Immunopharmacology [Elsevier BV]
卷期号:141: 112896-112896 被引量:3
标识
DOI:10.1016/j.intimp.2024.112896
摘要

Colorectal cancer (CRC), as a fatal cancer, is one of the most common cancers worldwide. Although the standard treatment for colorectal cancer is well researched and established, long-term patient survival remains poor, and mortality remains high. Therefore, more and more effective treatment options are needed. To evaluate the efficacy of bevacizumab, the histone demethylase inhibitor IOX1, or their combination for the treatment of colorectal cancer, we examined the effects of IOX1, bevacizumab, and IOX1 combined with bevacizumab on cell activity, proliferation, and migration of colorectal cancer cell lines HCT116, RKO, and CT26 by CCK8, colony formation assay, wound healing assay, and transwell assay. The effects of the drugs alone as well as in combination on apoptosis in colorectal cancer cell lines were examined by flow cytometry and further validated by Western blotting for apoptosis-related proteins. The antitumor effects of treatment alone or in combination on colorectal cancer cells were examined in animal models. Mice were injected subcutaneously with CT26 cells and the growth and immune infiltration in tumor tissues were detected by IHC after drug treatment. We found that IOX1 could effectively inhibit the activity of CRC cells and had a significant inhibitory effect on the proliferation and migration of CRC cells. The apoptosis rate increased in a dose-dependent manner after IOX1 treatment on colorectal cancer cells, and the expression of apoptosis-related proteins changed accordingly. Further combination with bevacizumab revealed that the combination had a more significant effect on the proliferation, migration, and apoptosis of CRC cells than either IOX1 or bevacizumab alone. In vivo experiments have found that both alone and combination drugs can inhibit the growth of mouse tumors, but the effect of combination inhibition is the most obvious. Combination therapy significantly inhibited the expression of proliferative marker (Ki67) in tumor xenograft models, and increased content of antigen-specific CD4
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S的应助被郑瑞欣采纳,获得10
1秒前
声声发布了新的文献求助10
2秒前
3秒前
3秒前
4秒前
怡然蘑菇完成签到,获得积分10
4秒前
Dyying发布了新的文献求助10
4秒前
4秒前
慕青的应助被新嘟采纳,获得10
5秒前
ds发布了新的文献求助10
6秒前
8秒前
霸气乐荷完成签到 ,获得积分10
9秒前
哈哈哈完成签到 ,获得积分10
9秒前
学做科研发布了新的文献求助10
9秒前
纸杯蛋糕完成签到 ,获得积分10
10秒前
10秒前
温庭筠发布了新的文献求助10
11秒前
11秒前
油面摊子完成签到,获得积分10
11秒前
Cbdd_发布了新的文献求助10
15秒前
郑瑞欣发布了新的文献求助10
15秒前
秋瑾完成签到,获得积分10
16秒前
李爱国的应助被斯文雅旋采纳,获得10
16秒前
午夜小南瓜完成签到 ,获得积分10
16秒前
温庭筠完成签到,获得积分10
16秒前
一丢丢完成签到,获得积分10
17秒前
科研通AI65的应助被科研通管家采纳,获得20
17秒前
星辰大海的应助被科研通管家采纳,获得10
17秒前
丘比特的应助被科研通管家采纳,获得30
17秒前
毅然决然必然完成签到,获得积分10
17秒前
17秒前
18秒前
脑洞疼的应助被科研通管家采纳,获得10
18秒前
核桃的应助被科研通管家采纳,获得30
18秒前
共享精神的应助被科研通管家采纳,获得10
18秒前
大模型的应助被科研通管家采纳,获得10
18秒前
fantasy的应助被科研通管家采纳,获得10
18秒前
18秒前
小北完成签到,获得积分10
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186875
求助须知:如何正确求助?哪些是违规求助? 9575211
关于积分的说明 21840004
捐赠科研通 7784592
什么是DOI,文献DOI怎么找? 3434866
关于科研通互助平台的介绍 2559266
邀请新用户注册赠送积分活动 2481717